RG6156
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
May 22, 2025
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
(clinicaltrials.gov)
- P1 | N=36 | Completed | Sponsor: Hoffmann-La Roche | Active, not recruiting ➔ Completed
Trial completion • Brain Cancer • Glioblastoma • Oncology • Solid Tumor
March 07, 2025
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
(clinicaltrials.gov)
- P1 | N=36 | Active, not recruiting | Sponsor: Hoffmann-La Roche | Trial completion date: Dec 2025 ➔ Mar 2025 | Trial primary completion date: Dec 2025 ➔ Mar 2025
Trial completion date • Trial primary completion date • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
December 27, 2024
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
(clinicaltrials.gov)
- P1 | N=36 | Active, not recruiting | Sponsor: Hoffmann-La Roche | N=200 ➔ 36
Enrollment change • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
September 20, 2024
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
(clinicaltrials.gov)
- P1 | N=200 | Recruiting | Sponsor: Hoffmann-La Roche | Active, not recruiting ➔ Recruiting
Enrollment open • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
May 24, 2024
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
(clinicaltrials.gov)
- P1 | N=200 | Active, not recruiting | Sponsor: Hoffmann-La Roche | Recruiting ➔ Active, not recruiting
Enrollment closed • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
August 01, 2023
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
(clinicaltrials.gov)
- P1 | N=200 | Recruiting | Sponsor: Hoffmann-La Roche | Trial completion date: Feb 2025 ➔ Dec 2025 | Trial primary completion date: Feb 2025 ➔ Dec 2025
Trial completion date • Trial primary completion date • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
1 to 6
Of
6
Go to page
1